LBA24 Neoadjuvant Immunotherapy in Locally Advanced MMR-deficient Colon Cancer: 3-Year Disease-Free Survival from NICHE-2
M. Chalabi, L.D.W. van den Dungen,Y.L. Verschoor,S. Balduzzi, P.G.M. de Gooyer,N. Kok, E. Kerver,C. Grootscholten,E.E. Voest,J.W.A. Burger,E.R. Hendriks,T.R. de Wijkerslooth,T. Tin,T.S. Aukema,S.J. Oosterling,A.G. Aalbers,J.G. van den Berg,M.E. van Leerdam,T.N. Schumacher,J.B.A.G. Haanen Annals of Oncology（2024）
AI 理解论文
溯源树
样例
